Acceleron is a Cambridge, Massachusetts-based biopharmaceutical company dedicated to the discovery and development of innovative, life-changing medicines for patients with serious and rare diseases. Learn more about our clinical pipeline here.
Acceleron Pharma Inc. (NASDAQ: XLRN)
Events & Presentations
Nov 16, 2018
9:00 AM ESTAcceleron PAH R&D Deep Dive Event
Oct 2, 2018
9:30 AM EDTLEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
Sep 13, 2018
1:30 PM EDTMorgan Stanley 16th Annual Global Healthcare Conference
Aug 2, 2018
5:00 PM EDTAcceleron Q2 Earnings Call
Copyright West LLC. Minimum 15 minutes delayed.